Concepedia

Publication | Open Access

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

DOIFull Paper Access

87

Citations

25

References

2024

Year

Peter Borchmann, Justin Ferdinandus, Gundolf Schneider, Alden A. Moccia, Richard Greil, Mark P. Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm,
The Lancet

Abstract

Takeda Oncology.

References

YearCitations

Page 1